Hyperfine (NASDAQ:HYPR - Get Free Report) was upgraded by investment analysts at Wall Street Zen from a "sell" rating to a "hold" rating in a research note issued to investors on Monday, Wall Street Zen reports.
Several other equities analysts have also issued reports on the company. Weiss Ratings reissued a "sell (d-)" rating on shares of Hyperfine in a research note on Thursday, October 15th. BTIG Research reissued a "buy" rating and issued a $2.00 target price on shares of Hyperfine in a report on Tuesday, September 22nd. Loop Capital set a $2.00 price objective on shares of Hyperfine in a report on Tuesday, October 27th. Lucid Cap Mkts began coverage on Hyperfine in a report on Tuesday, October 27th. They issued a "strong-buy" rating for the company. Finally, B. Riley Financial reiterated a "buy" rating and set a $1.60 price target (down from $2.00) on shares of Hyperfine in a research note on Monday, August 10th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, one has given a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, Hyperfine presently has an average rating of "Moderate Buy" and a consensus price target of $2.02.
Read Our Latest Stock Analysis on Hyperfine
Hyperfine Stock Performance
NASDAQ:HYPR opened at $0.63 on Monday. The company's 50-day moving average is $0.78 and its two-hundred day moving average is $1.10. The company has a debt-to-equity ratio of 0.42, a current ratio of 5.10 and a quick ratio of 4.50. The firm has a market capitalization of $66.83 million, a price-to-earnings ratio of -2.10 and a beta of 1.50. Hyperfine has a 1-year low of $0.61 and a 1-year high of $1.94.
Hyperfine (NASDAQ:HYPR - Get Free Report) last announced its quarterly earnings results on Monday, November 9th. The company reported ($0.07) EPS for the quarter, beating the consensus estimate of ($0.08) by $0.01. Hyperfine had a negative return on equity of 91.18% and a negative net margin of 156.42%. The business had revenue of $5.96 million for the quarter, compared to analyst estimates of $5.84 million. Analysts forecast that Hyperfine will post -0.34 EPS for the current year.
Institutional Investors Weigh In On Hyperfine
A number of institutional investors have recently bought and sold shares of HYPR. Russell Investments Group Ltd. grew its holdings in shares of Hyperfine by 7,695.4% during the 3rd quarter. Russell Investments Group Ltd. now owns 487,994 shares of the company's stock worth $394,000 after purchasing an additional 481,734 shares during the period. Renaissance Technologies LLC increased its stake in Hyperfine by 100.2% during the 1st quarter. Renaissance Technologies LLC now owns 730,233 shares of the company's stock worth $789,000 after buying an additional 365,490 shares during the period. Bank of New York Mellon Corp acquired a new stake in Hyperfine during the 2nd quarter valued at approximately $419,000. Empowered Funds LLC bought a new stake in shares of Hyperfine in the third quarter worth $78,000. Finally, Global Retirement Partners LLC raised its stake in shares of Hyperfine by 371.6% in the 3rd quarter. Global Retirement Partners LLC now owns 40,084 shares of the company's stock valued at $32,000 after purchasing an additional 31,584 shares in the last quarter. 15.03% of the stock is currently owned by hedge funds and other institutional investors.
Hyperfine Company Profile
(
Get Free Report)
Hyperfine, Inc. develops portable magnetic resonance imaging (MRI) technology for brain imaging. Its Swoop system is a low-field MRI scanner designed to bring imaging to patients at the point of care, including settings where access to conventional MRI equipment may be limited. The Swoop system is designed for use near a patient's bedside and does not require a dedicated MRI suite. The U.S. Food and Drug Administration cleared the system in 2020, marking a milestone for the use of portable MRI in clinical care.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Hyperfine, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hyperfine wasn't on the list.
While Hyperfine currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.